ArticleBMC nephrology2020

A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report.

Keisuke Horikoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.